High Court Won't Look At 3rd Circ. Ruling On Eyedrop Size
The U.S. Supreme Court on Monday refused to review a Third Circuit ruling that revived a proposed class action accusing Allergan Inc., Pfizer Inc. and other drugmakers of ripping off consumers...To view the full article, register now.
Already a subscriber? Click here to view full article